| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |